Stockreport

Editas Medicine: Primed For An Unlikely Comeback? It's Not Impossible [Seeking Alpha]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF The company is valued near cash levels, with $221M on hand, and aims to declare two in-vivo candidates by mid-2025, targeting HSCs and liver. Patent disputes and comp [Read more]